-
Cell motility and migration as determinants of stem cell efficacy
Study
EGAS00001002478
-
Telomerase activation by genomic rearrangements in high-risk neuroblastoma
Study
EGAS00001001308
-
Long-read sequencing for cell-free DNA analysis (human)
Study
EGAS00001006328
-
Human_primary_melanoma_project
Study
EGAS00001002409
-
Non-Mendalian inheritance of extrachromosal DNA elements can drive disease evolution in glioblastoma
Study
EGAS00001001878
-
ICGC medulloblastoma whole genome sequencing data, ICGC release 16
Study
EGAS00001000744
-
Spatiotemporal genomic architecture informs precision oncology in glioblsatoma
Study
EGAS00001001880
-
Chordoma_Extension_Study
Study
EGAS00001000892
-
Pharmacogenomic landscape of patient-derived cells informs precision oncology therapy
Study
EGAS00001002515
-
Deep single-cell RNA sequencing data for 12346 T cells from tumour, adjacent normal tissue and peripheral blood of treatment-naive NSCLC patients
Study
EGAS00001002430
-
Genome-wide genetic and epigenetic dataset of pancreatic acinar cell carcinomas
Study
EGAS00001002533
-
The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space
Study
EGAS00001002538
-
PanCuRx Translational Research Initiative
Study
EGAS00001002543
-
Exome sequencing data from two myelosarcomas
Study
EGAS00001002562
-
Automated system for scoring hematoxylin and eosin-stained ovarian cancer sections by identifying single cells uncovered that stromal cell ratio is a significant predictor for overall survival and progression-free survival.
Study
EGAS00001001694
-
Comparative genomics research for Chinese colorectal cancer
Study
EGAS00001002576
-
Inhibiton of the GABPB1L-containing GABP tetramer is sufficient to reverse replicative immortality in TERT promoter mutant glioblastoma cells.
Study
EGAS00001002582
-
Systematic kinase inhibitor profiling identifies CDK9 as a synthetic lethal target in NUT midline carcinoma
Study
EGAS00001002588
-
High Grade Serous Ovarian Carcinomas Originate in the Fallopian Tube
Study
EGAS00001002589
-
UQCCR/QCMG brain metastasis sequence analysis
Study
EGAS00001000722
-
The exomic landscape of t(14,18) negative diffuse follicular lymphoma with 1p36 deletion
Study
EGAS00001002594
-
Whole Genomes Define Concordance in Matched Primary, Xenograft, and Organoid Models of Pancreas Cancer
Study
EGAS00001002597
-
Identification of a Fumarate-Hydratase Deficient-like RCC Subtype with Convergent Pathway Alterations
Study
EGAS00001002646
-
Detection of clinically relevant genetic and transcriptomic landscape in DLBCL uniformly treated by R-CHOP
Study
EGAS00001002657
-
Gut microbiome modulates response to anti PD1 immunotherapy in metastatic melanoma patients
Study
EGAS00001002698
-
Genome-wide expression profiles to compare array-based, RNAseq and NanoString technologies in patients with resected pancreatic ductal carcinoma.
Study
EGAS00001002501
-
Whole exome sequencing of cell-free DNA reveals temporo-spatial heterogeneity and identifies treatment-resistant clones in neuroblastoma
Study
EGAS00001002705
-
MutWP1__CRUK_Grand_Challenge_Mutographs_of_Cancer__pancreas
Study
EGAS00001002726
-
Aggressive genomic features in clinicallyindolent primary HHV8-negative effusion-based lymphoma
Study
EGAS00001002743
-
Whole exome sequencing (bam files) of 55 samples of myxofibrosarcoma and 44 matched pairs
Study
EGAS00001005442
-
Diverse modes of genomic alterations in hepatocellular carcinoma
Study
EGAS00001000824
-
Defective T-cell expansion in RASGRP1 deficiency
Study
EGAS00001002753
-
Colorectal adenomas and carcinomas NKI-AvL TGO series Gut2009
Study
EGAS00001002758
-
Genomic analysis of Smoothened inhibitor resistance in basal cell carcinoma
Study
EGAS00001000845
-
Comprehensive genetic analysis of uveal melanoma heterogeneity during metastatic progression
Study
EGAS00001002761
-
Targeted_analysis_of_chondrosarcoma_cancer_genes
Study
EGAS00001001765
-
An Empirical Approach Leveraging Tumorgrafts to Dissect the Tumor Microenvironment in Renal Cell Carcinoma Identifies Missing Link to Prognostic Inflammatory Factors
Study
EGAS00001002786
-
RNA_seq_analysis_of_transcriptome_variation_with_human_ESC_subclones
Study
EGAS00001001655
-
An RCOR1 loss-associated gene expression signature identifies a prognostically significant DLBCL subgroup
Study
EGAS00001001000
-
Spatio-temporal evolution of the primary glioblastoma genome (newly added after 2015)
Study
EGAS00001001800
-
Molecular subtypes of malignant peritoneal mesothelioma
Study
EGAS00001002820
-
The Berlin (BLN) panel of glioblastoma cell lines: RNAseq of human gliomasphere cell lines and matched parental tumors
Study
EGAS00001001167
-
ChIP-seq data of Hodgkin lymphoma cell line L-428
Study
EGAS00001003033
-
A genomic approach towards an understanding of clonal evolution and disease progression in multiple myeloma
Study
EGAS00001002850
-
Clinical Implications of Genomic Alterations in the Tumor and Circulation of Pancreatic Cancer Patients
Study
EGAS00001001257
-
Whole exome sequencing of papillary thyroid carcinoma in the Chinese population
Study
EGAS00001001268
-
GBM cancer stem cell lines -RNA-seq and WGS data
Study
EGAS00001003700
-
Molecular_characterization_of_invasive_lobular_carcinoma
Study
EGAS00001000292
-
Angiosarcoma_whole_exome
Study
EGAS00001000588
-
Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma
Study
EGAS00001002928